Showing results (1921-1930 of 1,988) with videos related to

Sort By:
Pageof 199
ACS Chemical Neuroscience|December 16, 2020
Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of N-Methyl-d-aspartate ReceptorsKatie L Strong, Matthew P Epplin, Kevin K Ogden, et al.
Journal of Orthopaedic Trauma|June 5, 2024
Nonoperative Versus Operative Treatment of Z-Type Comminuted Clavicle Fractures in Adolescents: A Prospective Substratified Cohort AnalysisColeen S Sabatini, Eric W Edmonds, Jeffrey J Nepple, et al.
International Journal of Environmental Research and Public Health|October 28, 2015
Elimination of Mother-To-Child Transmission of HIV Infection: The Drug Resource Enhancement against AIDS and Malnutrition ModelGiuseppe Liotta, Maria Cristina Marazzi, Khethimipilo E Mothibi, et al.
Human Genetics|January 7, 1998
Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) regionP Manickam, S C Guru, L V Debelenko, et al.
Cancer Research|September 23, 2003
Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profilingSatoshi Nishizuka, Sing-Tsung Chen, Fuad G Gwadry, et al.
Plos One|November 6, 2009
Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patientsBih-Rong Wei, Shelley B Hoover, Mark M Ross, et al.
NPJ Biofilms and Microbiomes|November 21, 2017
New melanocortin-like peptide of E. coli can suppress inflammation via the mammalian melanocortin-1 receptor (MC1R): possible endocrine-like function for microbes of the gutXiaoling Qiang, Anthony S Liotta, Joseph Shiloach, et al.
Veterinary Parasitology|May 5, 2015
Macrocyclic lactone resistance in Dirofilaria immitis: Failure of heartworm preventives and investigation of genetic markers for resistanceCatherine Bourguinat, Alice C Y Lee, Regina Lizundia, et al.
Journal of Medicinal Chemistry|November 18, 2010
A novel pyrazolo[1,5-a]pyrimidine is a potent inhibitor of cyclin-dependent protein kinases 1, 2, and 9, which demonstrates antitumor effects in human tumor xenografts following oral administrationDean A Heathcote, Hetal Patel, Sebastian H B Kroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2020
Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast CancerDenis M Collins, Stephen F Madden, Nicola Gaynor, et al.
Pageof 199